DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
de Leon J, Susce MT, Pan RM. et al.
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.
J Clin Psychiatry 2005;
66: 15-27
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.